GMP consultants for pharmaceutical manufacturing companies in Vietnam

GMP-WHO CONSULTING

GMP-WHO Consulting Services – Good Manufacturing Practice for Pharmaceutical Manufacturing According to World Health Organization (WHO) Guidelines

I. INTRODUCTION TO GMP-WHO

Good Manufacturing Practice (GMP-WHO) is a pharmaceutical quality management system established by the World Health Organization (WHO) to ensure that medicinal products are consistently manufactured and controlled according to quality standards appropriate for their intended use and marketing authorization requirements.

GMP-WHO is recognized worldwide as a fundamental requirement for pharmaceutical manufacturing facilities and serves as the foundation for ensuring the safety, quality, efficacy, and consistency of pharmaceutical products.

In Vietnam, GMP-WHO requirements are regulated and supervised by the Ministry of Health (MOH) and the Drug Administration of Vietnam (DAV). Pharmaceutical manufacturers are required to comply with GMP principles as part of the licensing and regulatory approval process for pharmaceutical production activities.

II. OBJECTIVES OF GMP-WHO IMPLEMENTATION

The primary objectives of GMP-WHO implementation are to:

• Ensure pharmaceutical products are consistently produced according to approved quality standards.
• Protect patients from defective, contaminated, or ineffective medicines.
• Minimize risks associated with pharmaceutical manufacturing processes.
• Strengthen product quality assurance systems.
• Improve manufacturing efficiency and process control.
• Facilitate domestic and international market access.
• Meet regulatory requirements imposed by health authorities and customers.

III. WHY IS GMP-WHO IMPORTANT?

The pharmaceutical industry directly affects public health and patient safety. Unlike many consumer products, defects in pharmaceutical products may have serious consequences for patients.

GMP-WHO provides a systematic framework to prevent:

Cross-Contamination

Preventing contamination between products, raw materials, intermediates, and manufacturing environments.

Mix-Ups and Mislabeling

Preventing product identification errors, packaging mistakes, and labeling inaccuracies.

Quality Defects

Reducing risks associated with manufacturing deviations and process failures.

Data Integrity Issues

Ensuring the accuracy, completeness, consistency, and reliability of manufacturing and quality records.

Regulatory Non-Compliance

Maintaining compliance with national and international pharmaceutical regulations.

IV. KEY REQUIREMENTS OF GMP-WHO

1. Pharmaceutical Quality System (PQS)

Organizations shall establish and maintain a comprehensive Pharmaceutical Quality System covering:

• Quality Policy
• Quality Objectives
• Change Control
• Deviation Management
• CAPA (Corrective and Preventive Actions)
• Complaint Handling
• Product Recall Management
• Continuous Improvement Programs

2. Personnel

The organization shall ensure:

• Clearly defined organizational structure
• Qualified and competent personnel
• Initial and ongoing GMP training
• Personnel hygiene programs
• Defined responsibilities and authorities

3. Premises and Facilities

Facilities shall be designed, constructed, and maintained to minimize risks including:

• Cross-contamination
• Mix-ups
• Environmental contamination
• Product deterioration

Special attention shall be given to:

• Cleanroom design
• HVAC systems
• Material and personnel flow
• Water systems
• Waste handling systems

4. Equipment

Manufacturing and laboratory equipment shall be:

• Qualified
• Calibrated
• Maintained
• Cleaned
• Validated where required

Equipment shall be suitable for its intended use and capable of consistently delivering reliable results.

5. Documentation System

An effective documentation system is essential for GMP compliance.

Typical documentation includes:

• Quality Manual
• Standard Operating Procedures (SOPs)
• Batch Manufacturing Records
• Batch Packaging Records
• Validation Documentation
• Calibration Records
• Training Records
• Change Control Records
• Quality Control Records

All records shall be accurate, traceable, and retained according to regulatory requirements.

6. Production Control

Manufacturing activities shall be controlled to ensure product consistency and compliance.

Requirements include:

• Raw material control
• Line clearance procedures
• In-process controls
• Process monitoring
• Yield reconciliation
• Packaging controls
• Label controls

7. Quality Control Laboratory

Quality Control (QC) operations shall include:

• Incoming material testing
• In-process testing
• Finished product testing
• Stability studies
• Environmental monitoring
• Reference standard management
• OOS (Out-of-Specification) investigations

8. Qualification and Validation

GMP-WHO requires scientific evidence demonstrating that facilities, equipment, utilities, and processes consistently perform as intended.

Typical activities include:

• Design Qualification (DQ)
• Installation Qualification (IQ)
• Operational Qualification (OQ)
• Performance Qualification (PQ)
• Process Validation
• Cleaning Validation
• Analytical Method Validation
• Computerized System Validation (CSV)

9. Quality Risk Management

Modern GMP implementation follows risk-based approaches aligned with international guidelines.

Organizations should establish procedures for:

• Risk Identification
• Risk Assessment
• Risk Evaluation
• Risk Control
• Risk Monitoring

10. Data Integrity

Data Integrity has become one of the major inspection focuses worldwide.

Manufacturers shall implement controls based on ALCOA+ principles:

• Attributable
• Legible
• Contemporaneous
• Original
• Accurate
• Complete
• Consistent
• Enduring
• Available

V. BENEFITS OF GMP-WHO CERTIFICATION AND COMPLIANCE

Organizations implementing GMP-WHO may achieve:

Improved Product Quality

Ensures consistent production of safe and effective medicines.

Enhanced Regulatory Compliance

Facilitates compliance with Ministry of Health requirements and international regulatory expectations.

Increased Customer Confidence

Demonstrates commitment to quality, safety, and patient protection.

Reduced Operational Risks

Minimizes manufacturing deviations, complaints, recalls, and regulatory findings.

Improved Export Opportunities

Supports entry into international pharmaceutical markets.

Stronger Competitive Advantage

Enhances reputation among regulators, healthcare professionals, distributors, and customers.

VI. GMP-WHO CONSULTING PROCESS AT VINTECOM INTERNATIONAL

Step 1

Initial assessment of the manufacturing facility and quality management system.

Step 2

Conduct GMP-WHO Gap Assessment against current WHO GMP requirements and Ministry of Health regulations.

Step 3

Develop a GMP implementation roadmap and project plan.

Step 4

Provide GMP awareness and competency training for management and employees.

Step 5

Develop or upgrade GMP documentation and quality systems.

Step 6

Support implementation of GMP requirements throughout manufacturing operations.

Step 7

Assist with qualification, validation, and quality risk management activities.

Step 8

Conduct internal GMP audits and inspection readiness assessments.

Step 9

Support corrective actions and continuous improvement activities.

Step 10

Assist organizations during official GMP inspections conducted by competent regulatory authorities.

VII. GMP-WHO CONSULTING SERVICES PROVIDED BY VINTECOM INTERNATIONAL

VINTECOM International provides professional consulting and training services including:

• GMP-WHO Training Programs
• GMP Gap Assessment
• Pharmaceutical Quality System Development
• Documentation System Development
• Validation Master Plan (VMP) Development
• Process Validation Support
• Cleaning Validation Support
• Data Integrity Program Development
• Internal GMP Audits
• Inspection Readiness Programs
• GMP Facility Upgrade Projects

Our experienced consultants support pharmaceutical manufacturers from initial planning and implementation through successful regulatory inspections and sustainable GMP compliance.

By implementing GMP-WHO, pharmaceutical organizations can strengthen product quality, improve patient safety, meet regulatory requirements, and enhance competitiveness in both domestic and international markets.

📶📶📶 Contact us to register for GMP WHO and GMP Ministry of Health (MOH) Training, Consulting and Certification services.

Customers, organizations and enterprises require Training course, Consulting or Certification services of GMP-WHO, GMP-ASEAN, GMP PICs, please click on "Registration - Quotation" or on the right toolbar below the PC screen to receive a quotation for training, consulting and certification services.